Randomisation & Sample Size – Clinical BA Study [Power / Sample Size]

posted by Mike_270 – Australia, 2011-02-02 01:47 (5627 d 03:17 ago) – Posting: # 6533
Views: 8,270

Hi ElMaestro,

❝ In the absence of a model

❝ for it I guess you need to either conduct a pilot trial to get an idea

❝ about the effect size in your pivotal trial or press the 'I feel

❝ lucky'-button.


Thankyou for the advice. In terms of randomisation, did you have any comment about using the Williams design 4 treatment sequence design vs. a single treatment sequence (eg. ABCD)? Is it always better to randomise the treatment sequences even with small patient numbers?

Thanks again,

Michael

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
309 visitors (0 registered, 309 guests [including 32 identified bots]).
Forum time: 06:04 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5